OMICS Group Conferences

2nd World Congress on


Biomarkers & Clinical Research


September 12-14, 2011 | BWI Airport Marriott, Baltimore, USA
OMICS ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQ'S BLOG CONTACT FEEDBACK

SPONSORS
Biomarkers-2011 Report
OMICS Group organized 2nd World Congress on Biomarkers & Clinical Research in the most populous city of United States, the seat of Clark Country, and an internationally renowned major resort city for shopping, and fine dining at BWI Airport Marriott on September 12-14, 2011. This annual conclave comprised of 10 Tracks and 44 sessions with a grand inaugural ceremony followed by a Keynote forum. The motive of this International conference was to emphasize on "Strategies and Developments in Biomarkers & Clinical Research."

The conference highlighted the following topics

• Personalized Medicine & Data Analysis
• Biomarkers in Drug Discovery
• Molecular Imaging and Dynamics
• Cancer Biomarkers
• Gene Expression Profiling and DNA Diagnostics
• Clinical Research and Bioethics
• Post Genomics: Drug and Biomarker Development
• Biomarkers Classification & Molecular Sequence Analysis

We take great pleasure to express our deep felt thanks to all the following keynote speakers:

Dr. Abdel Halim, Director, Daiichi-Sankyo Pharma Development, USA
Dr. Crispin R. Dass, Victoria University, Australia
Dr. Jean Gabert, Université de la Méditerranée, France
Mr. Jeremy Warren, NanoSight Ltd, UK

This meeting brought together eminent scientists, scholars and entrepreneurs from across 30 countries in which many critical issues were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided a brilliant information platform for researchers to communicate with international experts which resulted in great exchange of knowledge.

According to the feedback of the conference, most of our international participants expressed that they would like to attend the upcoming conferences. Depending on the warmly support and suggestions from all the participants we are quite confident in organizing Biomarkers-2012 in July which would be better and successful. All of us are looking forward to meeting you again.

OMICS Group will acknowledge with gratitude the support by FDA, Nanosight Ltd, AstraZeneca R&D, Biologics Consulting Group, Inc. Daiichi-Sankyo Pharma Development, etc.

We are also thankful to all the members of associated journals, Journal of Molecular Biomarkers & Diagnosis, Journal of Postgenomics: Drug & Biomarker Development. In addition, we would like to record our special thanks to Nanosight Ltd, UK for strengthening our event by conducting exhibition, which was an outstanding contribution for the success of the conference.

Expert Presentations
Dr. Abdel Halim

Director, Daiichi-Sankyo Pharma Development,

USA
Dr. Crispin R. Dass

Victoria University,

Australia
Dr. Jean Gabert

Universite de la Mediterranee,

France
Mr. Jeremy Warren

NanoSight Ltd,

UK
Follow us on
Conference Secretariat: Biomarkers-2011, OMICS Group Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Editors-Journal of Molecular Biomarkers & Diagnosis and Journal of Postgenomics: Drug & Biomarker Development
The Organizers reserve the rights to make changes and adjustment to the information in this website
© Copyright 2008-2012 OMICS Group - All rights reserved